PubMed Health⌕ Search

Biomedical subjects

C Carobi

Publications and source records attributed to C Carobi.

At least 37 records · Page 2Linked to original sources
PubMed1981

The afferent innervation of the liver: a horseradish peroxidase study in the rat.

Scattered injections of horseradish peroxidase (HRP) into the rat liver produced labeling of a small number of large neurons located only in the rostral pole of the left nodose ganglion. The same amount injected in a single lobe also produced labeling of a few cells in Th7-Th10 dorsal root ganglia. No retrograde marking followed subcapsular injections. HRP injections around the porta hepatis yielded labeling of large and small neurons in the left nodose ganglion only. This indicates that most of the afferent fibers are of vagal origin, and that different receptors are located in different parts of the liver.

Afferent Pathways↗
PubMed1980

Positive aluminium balance in patients on regular peritoneal treatment: an effect of low dialysate pH?

Aluminium concentration was determined in dialysates used for HD and for PD and in the serum of normal subjects and of uraemic patients on treatment with HD and with PD. The main finding of this study was that serum A1 levels are significantly higher in patients on PD than in patients on HD. We conclude that the use of dialysates with pH less than 5.5 could contribute to a positive balance of A1 during PD.

Adolescent↗
PubMedDate not supplied

Left ventricular hypertrophy in daily dialysis.

Cardiac hypertrophy, a well-known independent risk factor for cardiovascular death, is a very frequent complication in ESRD patients. Its frequency tends to be even higher in dialyzed patients due to the fact that the current dialytic treatments are unable to keep under a satisfactory control the various responsible factors and particularly the blood pressure, which is largely the most important. Daily hemodialysis, a more frequent schedule consisting of 6-7 sessions/week lasting 2 or more hours, has definitely proved its superiority in controlling blood pressure and in improving anemia, and thus has the requisites for positively influencing cardiac hypertrophy. In fact, a series of studies, both retrospective and prospective, performed during the last years by our group, have confirmed that this new, more frequent and thus more physiological schedule, is able not only to stop the progression of the cardiac hypertrophy in uremic patients but also to revert toward the normality, in a relatively short time. This appears to be essentially a consequence of the excellent blood pressure control, which in turn derives from the easier control of the true dry weight, achievable with this type of dialytic treatment.

Adult↗
PubMedDate not supplied

[Uremic neuropathy. Study of the motor conduction rate in patients treated with maintenance hemodialysis and peritoneal dialysis].

Forty-four patients, treated with different systems of dialysis (peritoneal dialysis, two-weekly and three-weekly hemodialysis) have been controlled by electroneurographic, electromyographic and ematochimical examinations during a six months to five years period. The results can be summarized as follow: a) motor nerve conduction velocity of the peroneal nerve is reduced proportionally to the clinical status in all patients. Motor nerve conduction velocity of the ulnar nerve is reduced only in the most severe cases; b) there are no significant correlations between the examined ematochimical data and the maximal motor nerve conduction velocity; c) there is a slight improvement of the maximal motor nerve conduction velocity of the peroneal nerve when passing from a twelve hours two weekly dialytic treatment to a five hours three weekly hemodialytic treatment. Motor nerve conduction velocity is therefore a reliable index of insufficient or adequate dialysis. Moreover it is confirmed the efficacy of a treatment with short and frequent dialytic sessions.

Adult↗